Indication
Symptomatic treatment of adult patients with overactive bladder (OAB) syndrome.
Medicine details
- Medicine name:
- vibegron (Obgemsa)
- SMC ID:
- SMC2696
- Pharmaceutical company
- Pierre Fabre
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Abbreviated
- Publication due date:
- 09 December 2024